Standard treatments currently used for patients with exudative AMD (wet AMD) include intravitreous injections of anti-vascular endothelial growth factor (VEGF) drugs, photodynamic therapy, or a combination of both. This evidence concerns the gene VEGFA and wet macular degeneration.